Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

The use of inhaled, fixed-dose, long-acting muscarinic antagonists (LAMA) combined with long-acting, beta(2)-adrenergic receptor agonists (LABA) has become a mainstay in the maintenance treatment of chronic obstructive pulmonary disease (COPD). One of the fixed-dose LAMA/LABA combinations is the dry...

Descripción completa

Detalles Bibliográficos
Autores principales: Albertson, Timothy E, Bowman, Willis S, Harper, Richart W, Godbout, Regina M, Murin, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559138/
https://www.ncbi.nlm.nih.gov/pubmed/31239659
http://dx.doi.org/10.2147/COPD.S191845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559138/
https://www.ncbi.nlm.nih.gov/pubmed/31239659
http://dx.doi.org/10.2147/COPD.S191845

Ejemplares similares